{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:23:24Z","timestamp":1795026204440,"version":"4.10.2"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118743","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:54:49Z","timestamp":1762955689000},"page":"118743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Exploring the impact of metformin on the central nervous system and neurotransmission: A systematic review"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5709-0269","authenticated-orcid":false,"given":"Aleksandra","family":"Maciejczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Blecharz-Klin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12933-020-01202-5","article-title":"Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc Diabetol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118743_bib2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.biopha.2025.118743_bib3","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"51","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118743_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113686","article-title":"Mechanism of metformin regulation in central nervous system: Progression and future perspectives","volume":"156","author":"Cao","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4103\/1673-5374.385286","article-title":"Promising use of metformin in treating neurological disorders: biomarker-guided therapies","volume":"19","author":"Loan","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2025.118743_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fendo.2018.00400","article-title":"The therapeutic potential of metformin in neurodegenerative diseases","volume":"9","author":"Rotermund","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118743_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5604\/17322693.1093217","article-title":"Metformin as a key to alternative activation of microglia?","volume":"68","author":"\u0141abuzek","year":"2014","journal-title":"Post. Hig. Med Dosw"},{"issue":"8","key":"10.1016\/j.biopha.2025.118743_bib8","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s00415-019-09366-1","article-title":"A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury","volume":"266","author":"Taheri","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2025.118743_bib9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.biopha.2025.118743_bib10","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.biopha.2025.118743_bib11","unstructured":"Abou-Setta A.M. BL, Jones C.A., et al. (2011) Appendix I, Newcastle-Ottawa Scale Assessment of Cohort Studies. Available from \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK56664\/\u3009."},{"key":"10.1016\/j.biopha.2025.118743_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Method."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0005-2736(01)00352-2","article-title":"Depolarization of the liver cell membrane by metformin","volume":"1513","author":"Lutz","year":"2001","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","volume":"12","author":"Tucker","year":"1981","journal-title":"Br. J. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"\u0141abuzek","year":"2010","journal-title":"Pharm. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.biopha.2025.118743_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158281","article-title":"Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders","volume":"23","author":"Li","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051357","article-title":"Permeability of Metformin across an In Vitro Blood-Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)","volume":"15","author":"Sharma","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib20","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.124.002152","article-title":"Evaluation of systemic and brain pharmacokinetic parameters for repurposing metformin using intravenous bolus administration","volume":"392","author":"Sharma","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2024.100042","article-title":"Metformin finding its way into the central nervous system: Combating neurological diseases?","volume":"392","author":"Cignarella","year":"2025","journal-title":"J. Pharm. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"25","key":"10.1016\/j.biopha.2025.118743_bib23","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.3748\/wjg.v12.i25.4064","article-title":"Intestinal permeability of metformin using single-pass intestinal perfusion in rats","volume":"12","author":"Song","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.01.035","article-title":"Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin","volume":"202","author":"Hemauer","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2025.118743_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainresbull.2021.02.018","article-title":"Cholinergic and metabolic effects of metformin in mouse brain","volume":"170","author":"Thinnes","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib27","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1073\/pnas.0807991106","article-title":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118743_bib28","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/ph16121714","article-title":"Metformin: the winding path from understanding its molecular mechanisms to proving therapeutic benefits in neurodegenerative disorders","volume":"16","author":"Isop","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/db06-1119","article-title":"Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study","volume":"56","author":"Sriwijitkamol","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1194\/jlr.P022905","article-title":"Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue","volume":"53","author":"Xu","year":"2012","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JMN:17:1:45","article-title":"AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation","volume":"17","author":"Culmsee","year":"2001","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0306-4522(02)00836-9","article-title":"5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells","volume":"117","author":"Garcia-Gil","year":"2003","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.1202390","article-title":"AMP-activated protein kinase restricts IFN-\u03b3 signaling","volume":"190","author":"Meares","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118743_bib34","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.4049\/jimmunol.0803563","article-title":"Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis","volume":"182","author":"Nath","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","article-title":"Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system","volume":"21","author":"Demar\u00e9","year":"2021","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105351","article-title":"Beneficial effects of metformin on the central nervous system, with a focus on epilepsy and lafora disease","volume":"22","author":"Sanz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118743_bib37","article-title":"Potential role of metformin in central nervous system with a focus on its mechanism of actions","author":"Bora","year":"2023","journal-title":"Int. J. Multidiscip. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11682-014-9348-2","article-title":"Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes","volume":"9","author":"Moulton","year":"2015","journal-title":"Brain Imaging Behav."},{"issue":"12","key":"10.1016\/j.biopha.2025.118743_bib39","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jdiacomp.2017.09.001","article-title":"Brain gray matter changes in type 2 diabetes mellitus: A meta-analysis of whole-brain voxel-based morphometry study","volume":"31","author":"Wu","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"7109","key":"10.1016\/j.biopha.2025.118743_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight","volume":"443","author":"Morton","year":"2006","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.biopha.2025.118743_bib41","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1523\/JNEUROSCI.2904-18.2019","article-title":"Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids","volume":"39","author":"Zemdegs","year":"2019","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118743_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biology9110359","article-title":"Metformin ameliorates lipopolysaccharide-induced depressive-like behaviors and abnormal glutamatergic transmission","volume":"9","author":"Chen","year":"2020","journal-title":"Biology"},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib43","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1007\/s12035-016-0085-y","article-title":"Metformin attenuates A\u03b2 pathology mediated through levamisole sensitive nicotinic acetylcholine receptors in a C. elegans model of alzheimer's disease","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.31887\/DCNS.2000.2.3\/fduval","article-title":"Serotonergic and noradrenergic function in depression: clinical correlates","volume":"2","author":"Duval","year":"2000","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2025.118743_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4651031","article-title":"Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus","volume":"2019","author":"Poggini","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2025.118743_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbi.2014.03.012","article-title":"Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation","volume":"41","author":"Andr\u00e9","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2025.118743_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.psyneuen.2013.10.014","article-title":"Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome","volume":"40","author":"Dinel","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11011-014-9540-5","article-title":"Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice","volume":"29","author":"Gupta","year":"2014","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies","volume":"24","author":"Moriguchi","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10100706","article-title":"Metformin enhances excitatory synaptic transmission onto hippocampal CA1 pyramidal neurons","volume":"10","author":"Chen","year":"2020","journal-title":"Brain Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bph.14519","article-title":"Metformin produces anxiolytic-like effects in rats by facilitating GABA(A) receptor trafficking to membrane","volume":"176","author":"Fan","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118743_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110307","article-title":"The safety and efficacy of metformin in fragile X syndrome: an open-label study","volume":"110","author":"Proteau-Lemieux","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.biopha.2025.118743_bib57","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin - a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in alzheimer's disease guest editor: Davide Brambilla","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2011.01.022","article-title":"Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes","volume":"220","author":"Bhutada","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118743_bib59","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.biopha.2016.10.043","article-title":"Effect of dietary supplementation of Padauk (Pterocarpus soyauxii) leaf on high fat diet\/streptozotocin induced diabetes in rats' brain and platelets","volume":"84","author":"Saliu","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118743_bib60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbi.2016.08.016","article-title":"Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model","volume":"258","author":"Arafa","year":"2016","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2025.118743_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173290","article-title":"Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease","volume":"881","author":"Pilipenko","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"13","key":"10.1016\/j.biopha.2025.118743_bib62","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00213-016-4301-2","article-title":"Differential metformin dose-dependent effects on cognition in rats: role of Akt","volume":"233","author":"Mostafa","year":"2016","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pharep.2019.04.015","article-title":"The protective effect of metformin in scopolamine-induced learning and memory impairment in rats","volume":"71","author":"Aksoz","year":"2019","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.biopha.2025.118743_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2013.11.001","article-title":"Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice","volume":"251","author":"Wang","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2011.06.005","article-title":"Insulin resistance impairs nigrostriatal dopamine function","volume":"231","author":"Morris","year":"2011","journal-title":"Exp. Neurol."},{"issue":"42","key":"10.1016\/j.biopha.2025.118743_bib66","doi-asserted-by":"crossref","first-page":"26438","DOI":"10.1073\/pnas.2009838117","article-title":"Metformin rescues parkinson's disease phenotypes caused by hyperactive mitochondria","volume":"117","author":"Mor","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118743_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw047","article-title":"Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of parkinson's disease via autophagy and mitochondrial ROS clearance","volume":"19","author":"Lu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159381","article-title":"Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons","volume":"11","author":"Bayliss","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118743_bib69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2020.00084","article-title":"Metformin protects from rotenone-induced nigrostriatal neuronal death in adult mice by activating AMPK-FOXO3 signaling and mitigation of angiogenesis","volume":"13","author":"El-Ghaiesh","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12640-016-9633-5","article-title":"Metformin prevented dopaminergic neurotoxicity induced by 3,4-Methylenedioxymethamphetamine administration","volume":"30","author":"Porceddu","year":"2016","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.biopha.2025.118743_bib71","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","article-title":"Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease","volume":"125","author":"Katila","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118743_bib72","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","article-title":"Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice","volume":"277","author":"Patil","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.118743_bib73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-med-081117-041238","article-title":"Metformin for treatment of fragile X syndrome and other neurological disorders","volume":"70","author":"Gantois","year":"2019","journal-title":"Annu Rev. Med."},{"key":"10.1016\/j.biopha.2025.118743_bib74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/jpet.528.991880","article-title":"Metformin potentiates glutamate-stimulated catecholamines release in rat brain","volume":"389","author":"Gonzalez","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3 Pt 2","key":"10.1016\/j.biopha.2025.118743_bib75","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.HYP.27.3.619","article-title":"Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats","volume":"27","author":"Petersen","year":"1996","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2012.03.016","article-title":"Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2025.118743_bib77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/7854_2012_223","article-title":"Repair of the CNS using endogenous and transplanted neural stem cells","volume":"15","author":"Trueman","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.biopha.2025.118743_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1362629","article-title":"A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial","volume":"15","author":"De Keersmaecker","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118743_bib79","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2147\/DDDT.S409373","article-title":"Metformin: a review of potential mechanism and therapeutic utility beyond diabetes","volume":"17","author":"Dutta","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib81","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/rej.2011.1238","article-title":"Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases","volume":"14","author":"Mendelsohn","year":"2011","journal-title":"Rejuvenation Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13293-025-00684-w","article-title":"Sex differences in cognition, anxiety-phenotype and therapeutic effect of metformin in the aged apoE-TR mice","volume":"16","author":"Lin","year":"2025","journal-title":"Biol. Sex. Differ."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib83","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","article-title":"Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-\u03baB activation: use of insulin to attenuate metformin's effect","volume":"1853","author":"Picone","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib84","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","article-title":"Rosiglitazone attenuates learning and memory deficits in Tg2576 alzheimer mice","volume":"199","author":"Pedersen","year":"2006","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118743_bib85","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118743_bib86","article-title":"Deciphering the roles of metformin in alzheimer's disease: a snapshot","volume":"12","author":"Liao","year":"2021","journal-title":"Front. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib87","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-180808","article-title":"Association between the use of antihyperglycemic drugs and dementia risk: a case-control study","volume":"66","author":"Bohlken","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024954","article-title":"Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus","volume":"9","author":"Shi","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib89","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz234","article-title":"Metformin and risk of alzheimer's disease among community-dwelling people with diabetes: a national case-control study","volume":"105","author":"Sluggett","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13195-021-00934-0","article-title":"The association of antidiabetic medications and mini-mental state examination scores in patients with diabetes and dementia","volume":"13","author":"Secnik","year":"2021","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib91","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/s41467-022-35157-w","article-title":"Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia","volume":"13","author":"Charpignon","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib92","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s11357-022-00568-6","article-title":"Diabetic patients treated with metformin during early stages of Alzheimer's disease show a better integral performance: data from ADNI study","volume":"44","author":"Pomilio","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.biopha.2025.118743_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.878304","article-title":"Association between specific type 2 diabetes therapies and risk of alzheimer's disease and related dementias in propensity-score matched type 2 diabetic patients","volume":"14","author":"Torrandell-Haro","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib94","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","article-title":"Effects of the insulin sensitizer metformin in alzheimer disease: pilot data from a randomized placebo-controlled crossover study","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-141332","article-title":"Metformin treatment alters memory function in a mouse model of alzheimer's disease","volume":"44","author":"DiTacchio","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib97","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-016-0082-7","article-title":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy","volume":"11","author":"Barini","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib98","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118743_bib99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnins.2018.00155","article-title":"Interplay between the gut-brain axis, obesity and cognitive function","volume":"12","author":"Agust\u00ed","year":"2018","journal-title":"Front Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib100","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","article-title":"Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice","volume":"101","author":"Li","year":"2012","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.biopha.2025.118743_bib101","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib102","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3233\/JAD-181240","article-title":"Metformin improves learning and memory in the SAMP8 mouse model of alzheimer's disease","volume":"68","author":"Farr","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib103","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2315106","article-title":"Metformin ameliorates A\u03b2 pathology by insulin-degrading enzyme in a transgenic mouse model of alzheimer's disease","volume":"2020","author":"Lu","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib104","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/13813455.2018.1534244","article-title":"Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer's disease","volume":"126","author":"Nassar","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.biopha.2025.118743_bib106","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00221-021-06176-8","article-title":"Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice","volume":"239","author":"Oliveira","year":"2021","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.biopha.2025.118743_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111864","article-title":"Romidepsin and metformin nanomaterials delivery on streptozocin for the treatment of Alzheimer's disease in animal model","volume":"141","author":"Zeng","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118743_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120538","article-title":"Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease","volume":"299","author":"Kazkayasi","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118743_bib109","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1096\/fj.201802718R","article-title":"Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner","volume":"33","author":"Zhang","year":"2019","journal-title":"Faseb J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s13311-022-01316-6","article-title":"Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice","volume":"20","author":"Zhao","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib111","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","article-title":"Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction","volume":"347","author":"Chiang","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165893","article-title":"Metformin preferentially provides neuroprotection following cardiac ischemia\/reperfusion in non-diabetic rats","volume":"1866","author":"Benjanuwattra","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib113","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db14-0287","article-title":"Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease","volume":"63","author":"Yarchoan","year":"2014","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib114","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118743_bib115","article-title":"Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients","volume":"2014","author":"Huang","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib116","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study","volume":"60","author":"Imfeld","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1471-4159.2011.07515.x","article-title":"Regulation of \u03b2-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease","volume":"120","author":"Sun","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118743_bib118","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.07.009","article-title":"Molecular links between Alzheimer's disease and diabetes mellitus","volume":"250","author":"Yang","year":"2013","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib119","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1011","article-title":"Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials","volume":"16","author":"Kopf","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib121","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer's disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pr."},{"issue":"8","key":"10.1016\/j.biopha.2025.118743_bib122","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","article-title":"Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology","volume":"12","author":"Abner","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib123","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","article-title":"Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology","volume":"60","author":"Beeri","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib124","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archneurol.2008.579","article-title":"Different patterns of cerebral injury in dementia with or without diabetes","volume":"66","author":"Sonnen","year":"2009","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib125","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the honolulu-Asia aging study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib126","doi-asserted-by":"crossref","first-page":"R1082","DOI":"10.1152\/ajpregu.00449.2010","article-title":"Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet","volume":"299","author":"Morris","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118743_bib127","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.freeradbiomed.2004.12.008","article-title":"Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity","volume":"38","author":"Choi","year":"2005","journal-title":"Free Radic. Biol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib128","first-page":"775","article-title":"The association between type 2 diabetes mellitus and parkinson's disease","volume":"10","author":"Cheong","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib129","article-title":"Analysis of the relationship between type II diabetes mellitus and parkinson's disease: a systematic review","volume":"2019","author":"Camargo Maluf","year":"2019","journal-title":"Park. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118743_bib130","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/mds.28551","article-title":"Type 2 diabetes as a determinant of parkinson's disease risk and progression","volume":"36","author":"Chohan","year":"2021","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.biopha.2025.118743_bib131","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/mds.29122","article-title":"The impact of type 2 diabetes in parkinson's disease","volume":"37","author":"Athauda","year":"2022","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050946","article-title":"Dose-response association of metformin with parkinson's disease odds in type 2 diabetes mellitus","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.biopha.2025.118743_bib133","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/mds.27128","article-title":"Glitazone use associated with reduced risk of Parkinson's disease","volume":"32","author":"Brakedal","year":"2017","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib134","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cge.13039","article-title":"Metformin as targeted treatment in fragile X syndrome","volume":"93","author":"Dy","year":"2018","journal-title":"Clin. Genet."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib135","article-title":"Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases","volume":"7","author":"Protic","year":"2019","journal-title":"Mol. Genet Genom. Med."},{"issue":"11","key":"10.1016\/j.biopha.2025.118743_bib136","article-title":"Metformin treatment in young children with fragile X syndrome","volume":"7","author":"Biag","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.biopha.2025.118743_bib137","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease","volume":"7","author":"Arnoux","year":"2018","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib138","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lali\u0107","year":"2008","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118743_bib139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JHD-170253","article-title":"Huntington's disease and diabetes: chronological sequence of its association","volume":"6","author":"Montojo","year":"2017","journal-title":"J. Huntingt. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib140","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-131847","article-title":"High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington's disease","volume":"40","author":"Hu","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118743_bib141","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","article-title":"Huntington's disease does not appear to increase the risk of diabetes mellitus","volume":"21","author":"Boesgaard","year":"2009","journal-title":"J. Neuroendocr."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib142","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JHD-130078","article-title":"Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patients","volume":"2","author":"Russo","year":"2013","journal-title":"J. Huntingt. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118743_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179283","article-title":"Metformin intake associates with better cognitive function in patients with Huntington's disease","volume":"12","author":"Herv\u00e1s","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.biopha.2025.118743_bib144","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1111\/bph.12655","article-title":"Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy","volume":"171","author":"Jiang","year":"2014","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118743_bib145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-014-0177-4","article-title":"Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion","volume":"11","author":"Liu","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118743_bib146","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12035-014-8866-7","article-title":"Chronic metformin preconditioning provides neuroprotection via suppression of NF-\u03baB-mediated inflammatory pathway in rats with permanent cerebral ischemia","volume":"52","author":"Zhu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118743_bib147","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.physbeh.2016.12.021","article-title":"Metformin protects the brain against ischemia\/reperfusion injury through PI3K\/Akt1\/JNK3 signaling pathways in rats","volume":"170","author":"Ge","year":"2017","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib148","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1212\/WNL.0000000000009951","article-title":"Association of prestroke metformin use, stroke severity, and thrombolysis outcome","volume":"95","author":"Westphal","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118743_bib149","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221076894","article-title":"Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes","volume":"13","author":"Tu","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.09.019","article-title":"Antidiabetic drugs and stroke risk. Current evidence","volume":"48","author":"Castilla-Guerra","year":"2018","journal-title":"Eur. J. Intern Med"},{"issue":"8","key":"10.1016\/j.biopha.2025.118743_bib151","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.03.007","article-title":"Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study","volume":"21","author":"Horsdal","year":"2012","journal-title":"J. Stroke Cereb. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib152","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/2396987316666617","article-title":"Impact of pre-stroke sulphonylurea and metformin use on mortality of intracerebral haemorrhage","volume":"1","author":"Wu","year":"2016","journal-title":"Eur. Stroke J."},{"issue":"9","key":"10.1016\/j.biopha.2025.118743_bib153","article-title":"Effect of metformin on outcome after acute ischemic stroke in patients with type 2 diabetes mellitus","volume":"31","author":"Kersten","year":"2022","journal-title":"J. Stroke Cereb. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib154","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.016","article-title":"Impact of metformin on the severity and outcomes of acute ischemic stroke in patients with type 2 diabetes mellitus","volume":"25","author":"Mima","year":"2016","journal-title":"J. Stroke Cereb. Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2014.07.006","article-title":"Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion","volume":"579","author":"Liu","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118743_bib156","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2014.03.003","article-title":"Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia\/macrophages and increased angiogenesis and neurogenesis following experimental stroke","volume":"40","author":"Jin","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.biopha.2025.118743_bib157","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/ejn.12556","article-title":"Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke","volume":"39","author":"Venna","year":"2014","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118743_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1912","article-title":"Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke","volume":"5","author":"Ruddy","year":"2019","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib159","first-page":"279","article-title":"Niedob\u00f3r witaminy B12 w praktyce klinicznej","volume":"9","author":"Starostka-Tatar","year":"2023","journal-title":"Lek. POZ"},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1041610211002511","article-title":"Cognitive impairment and vitamin B12: a review","volume":"24","author":"Moore","year":"2012","journal-title":"Int. Psychogeriatr."},{"issue":"12","key":"10.1016\/j.biopha.2025.118743_bib161","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1515\/CCLM.2007.356","article-title":"The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases","volume":"45","author":"Obeid","year":"2007","journal-title":"Clin. Chem. Lab Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118743_bib162","article-title":"Metformin-associated vitamin B12 deficiency: an underrecognized complication","volume":"2","author":"Thewjitcharoen","year":"2024","journal-title":"JCEM Case Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118743_bib163","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1530\/EC-19-0382","article-title":"Vitamin B12 deficiency and diabetic neuropathy in patients taking metformin: a cross-sectional study","volume":"8","author":"Alvarez","year":"2019","journal-title":"Endocr. Connect"},{"issue":"9","key":"10.1016\/j.biopha.2025.118743_bib164","article-title":"Vitamin B12 deficiency in patients taking metformin: pathogenesis and recommendations","volume":"16","author":"Ramzan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2025.118743_bib165","first-page":"30","article-title":"The side effects of metformin - A review","volume":"6","author":"Ghosal","year":"2019","journal-title":"J. Diabetes Metab. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2025.118743_bib166","doi-asserted-by":"crossref","first-page":"949","DOI":"10.14336\/AD.2019.0120","article-title":"Metformin alters locomotor and cognitive function and brain metabolism in normoglycemic mice","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2025.118743_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2021.100383","article-title":"Focal brain lactate accumulation in metformin-induced encephalopathy without systemic lactic acidosis: a case report suggesting mitochondrial vulnerability in lentiform fork sign","volume":"25","author":"Hanazono","year":"2021","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.biopha.2025.118743_bib168","article-title":"Case report: late-onset mitochondrial disease uncovered by metformin use in a patient with acute verbal Auditory Agnosia","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118743_bib169","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamainternmed.2018.0292","article-title":"Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study","volume":"178","author":"Lazarus","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.biopha.2025.118743_bib170","article-title":"Metformin-associated lactic acidosis in an older adult: a case report and review","author":"Jain","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2025.118743_bib171","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eurpsy.2018.08.002","article-title":"Schizophrenia in type 2 diabetes mellitus: prevalence and clinical characteristics","volume":"54","author":"Huang","year":"2018","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118743_bib172","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2017.09.044","article-title":"Major depressive disorder in patients with type 2 diabetes mellitus: prevalence and clinical characteristics","volume":"227","author":"Huang","year":"2018","journal-title":"J. Affect Disord."},{"issue":"2","key":"10.1016\/j.biopha.2025.118743_bib173","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:47:02Z","timestamp":1777013222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":173,"alternative-id":["S0753332225009370"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118743","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the impact of metformin on the central nervous system and neurotransmission: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118743"}}